期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基质金属蛋白酶及微血管密度和子宫内膜癌的关系

The relations of matrix metalloproteinases and the density of microvessel in tumours with endometrial carcinoma
暂未订购
导出
摘要 基质金属蛋白酶及其抑制剂在子宫内膜癌的侵袭和转移中发挥着重要的作用。肿瘤的新生血管对肿瘤的发生、发展、转移及预后有着重要作用。微血管密度是衡量血管生成的定量指标。基质金属蛋白酶抑制剂可抑制血管的生成和MMPs对细胞外基质的降解。现将他们与子宫内膜癌的关系综述如下。 Matrix metalloproteinases(MMPs)and tissue inhibitor of metalloproteinases(TIMPs) play important roles in the invasion and metastasis of endometrial carcinoma.The neogenetic blood vessels of tumor is of crucial role in occurrence, development, matastasis and prognosis of the tumor. The microvessel density(MVD)is a quantitative index of angiogenesis. TIMPs can inhibit not only angiogenesis but also degradation of extracellular matrix (ECM)by MMPs. We summarized the relations of the two substances with carcinoma of endometrium as follows.
作者 张宇靖 张首杰
机构地区 吉林大学第二临床医学院妇产科
出处 《国外医学（妇幼保健分册）》 2003年第6期425-427,共3页 Foreign Medical Sciences (Section of Maternal and Child Health)
关键词 基质金属蛋白酶 金属蛋白酶抑制剂 血管生成 子宫内膜癌 matrix metalloproteinases(MMPs) tissue inhibitor of metalloproteinases(TIMPs) angiogenesis endometrial carcinoma
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1[1]Garbett E A Reed M W,Brown N J, et al. Proteolysis in human breast and colorectalcancer[ J ]. Br J Ca ncer , 1999,81 (2): 287 -293.
  • 2[2]Maata M, Soini Y, Liakka A, et al. Localization of MT1-MMP,TIMP-1,TIMP-2,TIMP-3 and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differetiation[ J ]. Am J Clin Pathol, 2000,114 (3):402 - 411.
  • 3[3]Kugler A . Matrix metalloproteinases and their inhibitors [ J ].Anticancer Res , 1999,19(2c): 1589 - 1592.
  • 4[4]Ueno H,Yamashita K,Azumano I, et al. Enhanced prodution and activation of matrix metalloproteinase-7 (matrilysin)in human endometrial carcinomas[ J ]. Int J Cancer, 1999,84 ( 5 ): 470- 477.
  • 5[5]Lurlaro M , Loverro G , Vacca A, et al . Angiogensis extent and expression of matrix metalloproteinase-2 and-9 correlate with upgrading and myometrial invasion in endometrial carcinoma[J]. Eur J Clin Invest, 1999,29:793 - 801.
  • 6[6]Di N L A, Misajon A, Zhang J, et al. Presrnce of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion[J]. Cancer, 2002,94(5) :1466 - 1475.
  • 7[7]Lopata A, Agresta F, Quinn M A, et al. Detection of endomrtrial cancer by determination of matrix metalloproteinases in the uterine cavity[J] . Gynecol Oncol, 2003,90(2) :318 - 324.
  • 8[8]Ivsaka K, Nishi H, Nakada T, et al . Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma[J]. Cancer, 2003,97(1) :79 - 89.
  • 9[9]Tunuguntla R, Ripley D, Sang Q X, et al . Expression of matrix metalloproteinase-26 and tissue inhibirtors of metalloproteinase TIMP-3 and -4 in benign endometrium and endometrial cancer small star, filled[J]. Gynecol oncol. 2003,89(3) :453 -459.
  • 10[10]Di N L A, Jobling T, Salamonsen L A. Progestin suppresses matrix metalloproteinase production in endometrial cancer[J].Gynecol Oncol, 2003,89 (2): 325 - 333.
国外医学（妇幼保健分册）
2003年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部